alexa Dexmedetomidine might Reduce the Incidence of Chronic Postoperative Pain after Major Abdominal Surgery | OMICS International| Abstract

Anesthesiology Communications
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • Anesth Commun 2018, Vol 2(1): 102

Dexmedetomidine might Reduce the Incidence of Chronic Postoperative Pain after Major Abdominal Surgery

Jenko M*, Lukanovic NP, Jankovic VN and Vesel AS
University Medical Center of Ljubljana, , Ljubljana, Slovenia
*Corresponding Author : Jenko M, University Medical Center of Ljubljana, Ljubljana, Slovenia, Tel: +386 1 5437 702, Email: [email protected]

Received Date: Apr 10, 2018 / Accepted Date: May 22, 2018 / Published Date: May 26, 2018

Abstract

Aim: To evaluate influence of dexmedetomidine on incidence of chronic postoperative pain and neuropathic pain.
Background: Chronic postoperative pain (CPSP), pain that cannot be explained by other causes and that persist more than 2 months after surgery, occurs in 10-50% of patients after the major abdominal surgery. It is a medical problem with huge economic implications. Intraoperative infusion of dexmedetomidine (DEX), a selective alpha2 adrenoreceptor agonist and presence of epidural analgesia may affect the incidence of CPSP.
Method: Adult surgical patients from the Clinical department of abdominal surgery UMC Ljubljana that were planned to undergo one of the following procedures: stomach surgery, pancreas surgery or large intestinal resections, were included in this prospective study. All patients had epidural analgesia and intraoperative DEX infusion. Three months after the procedure, structured questionnaire was send to patients. The intensity and quality of pain were examined. DN4 (Douleur Neuropathique 4) and painDetect questionnaires were used.
Results: We have received 42 (50%) properly filled DN4 questionnaires and 45 (53%) pain-detect questionnaires. The incidence of neuropathic pain in our study was 7.1% (3 patients have met criteria for neuropathic pain according to DN4).
Conclusion: Our prospective study might suggest a favorable role of intraoperative dexmedetomidine infusion on post-operative incidence of chronic postoperative pain

Keywords: Dexmedetomidine; Neuropathic pain; Abdominal surgery

Citation: Jenko M, Lukanovic NP, Jankovic VN, Vesel AS (2018) Dexmedetomidine Might Reduce the Incidence of Chronic Post-operative Pain after Major Abdominal Surgery. Anesth Commun 2: 102.

Copyright: © 2018 Jenko M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 1349
  • [From(publication date): 0-2018 - Nov 24, 2020]
  • Breakdown by view type
  • HTML page views: 1224
  • PDF downloads: 125
Top